HIINX
Price
$61.72
Change
-$0.22 (-0.36%)
Updated
Aug 28 closing price
Net Assets
4.01B
VTPSX
Price
$187.87
Change
-$0.99 (-0.52%)
Updated
Aug 28 closing price
Net Assets
645.82B
Interact to see
Advertisement

HIINX vs VTPSX

HIINX vs VTPSX Comparison Chart in %
View a ticker or compare two or three
VS
HIINX vs. VTPSX commentary
Aug 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIINX is a Buy and VTPSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 646B vs. HIINX (4.01B). HIINX pays higher dividends than VTPSX: HIINX (2.95) vs VTPSX (2.59). HIINX was incepted earlier than VTPSX: HIINX (24 years) vs VTPSX (16 years). HIINX (1.23) is less costly to investors than VTPSX (0.05). HIINX is a more actively managed with annual turnover of: 17.00 vs. VTPSX (4.00). HIINX has a lower initial minimum investment than VTPSX: HIINX (2500) vs VTPSX (100000000). VTPSX annual gain was more profitable for investors over the last year : 23.12 vs. HIINX (18.05). HIINX return over 5 years is better than : 42.18 vs. VTPSX (39.52).
HIINXVTPSXHIINX / VTPSX
Total Expense Ratio1.140.052,280%
Annual Report Gross Expense Ratio1.230.052,460%
Fund Existence24 years16 years-
Gain YTD13.49816.14284%
Front LoadN/AN/A-
Min. Initial Investment25001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.01B646B1%
Annual Yield % from dividends2.952.59114%
Returns for 1 year18.0523.1278%
Returns for 3 years58.6960.6297%
Returns for 5 years42.1839.52107%
Returns for 10 years17.35102.3517%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWBX102.89-0.29
-0.28%
American Funds New World R-2
FIUIX33.08-0.20
-0.60%
Fidelity Telecom and Utilities
FVFRX66.72-0.61
-0.91%
Franklin Small Cap Value R
TRCSX20.80-0.30
-1.42%
T. Rowe Price Small-Cap Index I
RYBOX78.11-2.20
-2.74%
Rydex Biotechnology A